Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

James B Rottman

3PUBLICATIONS

21CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Feb 14, 2022

T-SIGn tumor reengineering therapy and CAR T cells synergize in combination therapy to clear human lung tumor xenografts and lung metastases in NSG mice.

Olmo Sonzogni, Daniel E Zak, Maria Stella Sasso

|Sep 05, 2021

Safety, Efficacy, and Biomarker Results from a Phase Ib Study of the Anti-DKK1 Antibody DKN-01 in Combination with Pembrolizumab in Advanced Esophagogastric Cancers.

Samuel J Klempner, Johanna C Bendell, Victoria Meucci Villaflor

|Dec 21, 2018

Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models.

Elizabeth A Killion, Jinghong Wang, Junming Yie

Pageof 1

Frequent Collaborators

1 joint publications

Elizabeth A Killion

1 joint publications

Jinghong Wang

1 joint publications

Junming Yie

1 joint publications

Stone D-H Shi

1 joint publications

Xiaoshan Min

1 joint publications

Renee Komorowski

1 joint publications

Shu-Chen Lu

1 joint publications

Robert J M Kurzeja

1 joint publications

Glenn Sivits

1 joint publications

Stephen A Thibault

Frequent Collaborators

1 joint publications

Elizabeth A Killion

1 joint publications

Jinghong Wang

1 joint publications

Junming Yie

1 joint publications

Stone D-H Shi

Top Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on : Oct 16, 2018

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of <em>Syzygium aromaticum</em> (Clove) and <em>Cuminun cyminum</em> (Cumin) on C57BL6/j Mice Fed High-Fat Diet

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of <em>Syzygium aromaticum</em> (Clove) and <em>Cuminun cyminum</em> (Cumin) on C57BL6/j Mice Fed High-Fat Diet

Published on : Jul 31, 2021

See more related videos

Top Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on : Oct 16, 2018

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of <em>Syzygium aromaticum</em> (Clove) and <em>Cuminun cyminum</em> (Cumin) on C57BL6/j Mice Fed High-Fat Diet

Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of <em>Syzygium aromaticum</em> (Clove) and <em>Cuminun cyminum</em> (Cumin) on C57BL6/j Mice Fed High-Fat Diet

Published on : Jul 31, 2021

See more related videos